Superior Parietal iTBS for PD-MCI
NCT: NCT07701785 · RECRUITING
NCT IDNCT07701785
StatusRECRUITING
Start Date2026-08-01
Completion2028-04-30
SponsorMedical University of South Carolina (OTHER)
First posted
Last updated
Brief Summary
The goal of this study is to determine the whether a short-term, high-dose form of non-invasive brain stimulation (intermittent theta burst stimulation; iTBS) is a promising and safe treatment for mild cognitive impairment in Parkinson's disease (PD-MCI).
Frequently Asked Questions
What is Superior Parietal iTBS for PD-MCI?
Superior Parietal iTBS for PD-MCI is a clinical trial registered under NCT07701785. Current status: RECRUITING.
What is the status of NCT07701785?
The current status of NCT07701785 (Superior Parietal iTBS for PD-MCI) is: RECRUITING.
When did Superior Parietal iTBS for PD-MCI start?
Superior Parietal iTBS for PD-MCI started on 2026-08-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.